ADTX Stock Analysis: Buy, Sell, or Hold?
ADTX - Aditxt, Inc. Common Stock
$0.01
-0.03 (-77.22%)
▼
5d:
-12.84%
30d:
-98.15%
90d:
-99.02%
WAIT
LOW Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When ADTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ADTX is down 12.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ADTX is down 12.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADTX is currently trading at $0.01, which is considered slightly low relative to its 30-day fair value range of $-0.21 to $0.80.
Technical Outlook: Technically, ADTX is in a downtrend. Immediate support is located at $0.00, while resistance sits at $0.06. Short-term momentum is weak, with the stock down 77.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.00 (+642005.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADTX is in a downtrend. Immediate support is located at $0.00, while resistance sits at $0.06. Short-term momentum is weak, with the stock down 77.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.00 (+642005.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$-0.21 -
$0.80
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-77.2%)
- BULLISH: Trading 642005.3% below Wall St target ($61.00)
- WARNING: Recommendation downgraded due to -12.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$-0.21 -
$0.80
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.00
Resistance Level
$0.06
Current Trend
Downtrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.35
Wall Street Target
$61.00
(+642005.3%)
Revenue Growth (YoY)
1094.4%
Share & Embed Analysis
Last updated: June 24, 2026 7:07 PM ET
Data refreshes hourly during market hours. Next update: 8:07 PM
Data refreshes hourly during market hours. Next update: 8:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADTX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Financial Lp Hrt
SELL
11982 shares
2026-04-22
Financial Lp Hrt
BUY
72912 shares
2026-04-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 60 BUY |
